Autor: "Ying Y" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Do beta-blockers reduce negative intrusive thoughts and anxiety in cancer survivors? - An emulated trial.
Autorzy:: Ehrencrona C; Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. .
Li Y; Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Biostatistics, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Angenete E; Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Haglind E; Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Franzén S; Medical & Payer Evidence Statistics, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Biostatistics, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Grimby-Ekman A; Biostatistics, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Bock D; Department of Surgery, SSORG - Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 11; Vol. 24 (1), pp. 447. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: Cancer Survivors*
Neoplasms*/complications
Neoplasms*/drug therapy
Neoplasms*/epidemiology
Male ; Humans ; Female ; Quality of Life ; Bayes Theorem ; Anxiety/epidemiology ; Anxiety/etiology ; Anxiety Disorders

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response.
Autorzy:: Qin Q; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China.
Zhou Y; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China.
Guo J; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China.
Chen Q; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.
Tang W; Department of Medical Oncology, School of Medicine, The First Affiliated Hospital of Xiamen University and Institute of Hematology, Xiamen University, Xiamen, 361003, China.; Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, The School of Clinical Medicine of Fujian, Medical University, Xiamen, 361003, China.
Li Y; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China.; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China.; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China.
You J; Department of Gastrointestinal Oncology Surgery, The First Affiliated Hospital of Xiamen University, Cancer Center, Xiamen, 361003, China.
Li Q; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, China. .; School of Medicine, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361102, China. .; Department of Pediatrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361003, China. .; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2024 Apr 02; Vol. 16 (1), pp. 47. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: DNA Methylation*
Neoplasms*/genetics
Neoplasms*/therapy
Humans ; Epigenesis, Genetic ; Tumor Microenvironment/genetics ; Gene Expression Profiling/methods ; Prognosis ; Immunotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy.
Autorzy:: Miao L; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, 116000, People's Republic of China.
Lu C; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.
Zhang B; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.
Li H; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, 116000, People's Republic of China.
Zhao X; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, 116000, People's Republic of China.
Chen H; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, 116000, People's Republic of China.
Liu Y; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China. .; Department of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People's Republic of China. .
Cui X; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Mar 03; Vol. 22 (1), pp. 229. Date of Electronic Publication: 2024 Mar 03.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Metabolic Reprogramming*
Neoplasms*/therapy
Humans ; Tumor Microenvironment ; Killer Cells, Natural ; Lactic Acid

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion.
Autorzy:: Zhao Z; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Qin J; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Qian Y; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Huang C; Fujian Provincial Hospital, Fuzhou, China.
Liu X; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Wang N; Huzhou Central Hospital, Affiliated Hospital of Zhejiang University, Zhejiang, China.
Li L; Huzhou Central Hospital, Affiliated Hospital of Zhejiang University, Zhejiang, China.
Chao Y; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Tan B; BRL Medicine Inc., Shanghai, China.
Zhang N; BRL Medicine Inc., Shanghai, China.
Qian M; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Li D; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Liu M; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China.
Du B; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology and School of Life Sciences, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China. .; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2024 Feb 24; Vol. 17 (1), pp. 9. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:: Journal Article
MeSH Terms:: Myeloid-Derived Suppressor Cells*
Neoplasms*
Adenocarcinoma of Lung*/metabolism
Humans ; Mice ; Animals ; Calcium/metabolism ; Peroxisome Proliferator-Activated Receptors/metabolism ; Arginine/metabolism ; Acetates/metabolism ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Reliability and validity of the cancer-related dysfunctional beliefs and attitudes about sleep scale in cancer patients.
Autorzy:: Gao Z; School of Nursing, Jinzhou Medical University, No.40, Section 3, Songpo Road, Linghe District, Jinzhou City, Liaoning Province, P.R. China.
Gao Z; Shengjing Hospital affiliated to China Medical University, Shenyang City, Liaoning Province, P.R. China.
Zheng C; School of Nursing, Jinzhou Medical University, No.40, Section 3, Songpo Road, Linghe District, Jinzhou City, Liaoning Province, P.R. China.
Ma J; College of Health Management, Liaoyang Vocational and Technical College, Liaoyang City, Liaoning Province, P.R. China.
Zhao Y; School of Nursing, Jinzhou Medical University, No.40, Section 3, Songpo Road, Linghe District, Jinzhou City, Liaoning Province, P.R. China.
Zhang L; Department of Internal Medicine Nursing, School of Nursing, Wannan Medical College, 22 Wenchang West Road, Higher Education Park, Wuhu City, An Hui Province, P.R. China. .
Guo L; School of Nursing, Jinzhou Medical University, No.40, Section 3, Songpo Road, Linghe District, Jinzhou City, Liaoning Province, P.R. China. .; Pokaż więcej
Źródło:: BMC psychiatry [BMC Psychiatry] 2024 Feb 20; Vol. 24 (1), pp. 144. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:: Journal Article
MeSH Terms:: Quality of Life*
Neoplasms*/complications
Humans ; Reproducibility of Results ; Surveys and Questionnaires ; Sleep ; Psychometrics/methods ; China

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Immunogram defines four cancer-immunity cycle phenotypes with distinct clonal selection patterns across solid tumors.
Autorzy:: Hu Y; Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
Sun H; Beijing SinoMDgene Technology CO., LTD, Beijing, 100176, China.
Shi W; Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Chen C; Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
Wu X; Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
Jiang Y; Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
Zhang G; Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
Li N; Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
Song J; Beijing Immupeutics Medicine Technology Limited, Beijing, 102609, China.
Zhang H; Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Shen B; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .; State Key Laboratory of Oncogenes and Related Genes, National Research Center for Translational Medicine (Shanghai), Shanghai, 200025, China. .
Zeng H; Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. .; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. .
Zhang H; Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. .; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. .; Beijing Engineering Research Center of Immunocellular therapy, Beijing, 102609, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Jan 20; Vol. 22 (1), pp. 69. Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplasms*/therapy
Humans ; Immunotherapy/methods ; Phenotype ; Prognosis ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Perspectives of telemedicine-based services among family caregivers of patients with end-of-life cancer: a qualitative study in mainland China.
Autorzy:: Guo J; Department of Palliative Care, Hunan Cancer Hospital, No.283, Tongzipo Road, Yuelu District, Changsha, 410006, Hunan, China.; School of Nursing, University of South China, No.28, Changsheng West Road, Hengyang, 421001, Hunan, China.
Xu X; Department of Palliative Care, Hunan Cancer Hospital, No.283, Tongzipo Road, Yuelu District, Changsha, 410006, Hunan, China.
Liu C; Department of Palliative Care, Hunan Cancer Hospital, No.283, Tongzipo Road, Yuelu District, Changsha, 410006, Hunan, China.
Wang Y; Department of Palliative Care, Hunan Cancer Hospital, No.283, Tongzipo Road, Yuelu District, Changsha, 410006, Hunan, China.
Chen Y; Department of Palliative Care, Hunan Cancer Hospital, No.283, Tongzipo Road, Yuelu District, Changsha, 410006, Hunan, China. .; Pokaż więcej
Źródło:: BMC palliative care [BMC Palliat Care] 2024 Jan 12; Vol. 23 (1), pp. 16. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:: Journal Article
MeSH Terms:: Telemedicine*
Neoplasms*/therapy
Humans ; Caregivers/psychology ; Palliative Care/methods ; Qualitative Research ; Death ; Family/psychology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Tumor-targeting hydroxyapatite nanoparticles for remodeling tumor immune microenvironment (TIME) by activating mitoDNA-pyroptosis pathway in cancer.
Autorzy:: Yang Y; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China.
Yang J; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China.; Department of General Surgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 441021, China.
Zhu N; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China.
Qiu H; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China.
Feng W; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China.
Chen Y; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China.
Chen X; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China.
Chen Y; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China.
Zheng W; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China.
Liang M; Department of Oncology, Innovation Centre for Advanced Interdisciplinary Medicine, Guangzhou Key Laboratory of Enhanced Recovery after Abdominal Surgery, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510700, China. .
Lin T; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China. .
Yu J; Department of General Surgery, Nanfang Hospital, Southern medical University, Guangzhou, 510515, China. .
Guo Z; Breast Division, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2023 Dec 07; Vol. 21 (1), pp. 470. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplasms*/drug therapy
Nanoparticles*
Humans ; Pyroptosis ; Durapatite ; Calcium ; Tumor Microenvironment ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Inflammasomes/metabolism ; Reactive Oxygen Species/metabolism ; Caspase 1/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: The crosstalk between ferroptosis and autophagy in cancer.
Autorzy:: Lv X; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Wang B; Medicine School of Hexi College, Zhangye, Gansu, China.
Dong M; Gumei community Health center of Minhang district of Shanghai, Shanghai, China.
Wang W; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Tang W; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Qin J; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Gao Y; Medicine School of Hexi College, Zhangye, Gansu, China.
Wei Y; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.; Pokaż więcej
Źródło:: Autoimmunity [Autoimmunity] 2023 Dec; Vol. 56 (1), pp. 2289362. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Ferroptosis*
Neoplasms*
Asthma*
Humans ; Autophagy ; Cross Reactions

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: The experiences of reproductive concerns in cancer survivors: A systematic review and meta-synthesis of qualitative studies.
Autorzy:: Dong Y; LiaoNing Cancer Hospital & Institute, DaLian Medical University School of Nursing, Shenyang, China.
Yue Z; LiaoNing Cancer Hospital & Institute, Shenyang, China.
Zhuang H; Third Department of Gynecology, LiaoNing Cancer Hospital & Institute, Shenyang, China.
Zhang C; DaLian Medical University School of Nursing, Dalian, China.
Fang Y; DaLian Medical University School of Nursing, Dalian, China.
Jiang G; Clinical Skills Training Center, LiaoNing Cancer Hospital & Institute, Shenyang, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 22224-22251. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Cancer Survivors*/psychology
Neoplasms*/therapy
Neoplasms*/psychology
Male ; Humans ; Female ; Qualitative Research ; Fertility ; Counseling

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: COVID-19 in cancer patients: The impact of vaccination on outcomes early in the pandemic.
Autorzy:: Khawaja F; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Angelidakis G; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Feldman A; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ravi V; Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Woodman E; Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Bhatti M; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ariza-Heredia E; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Elhajj P; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Spallone A; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jiang Y; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Chemaly RF; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 22006-22022. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
COVID-19*/prevention & control
Neoplasms*/epidemiology
Neoplasms*/therapy
Humans ; Middle Aged ; Pandemics ; SARS-CoV-2 ; COVID-19 Vaccines ; Retrospective Studies ; Vaccination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapy.
Autorzy:: Fu Y; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.
Kong Y; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.
Li X; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.
Cheng D; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.
Hou Y; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.
Li Y; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.
Li T; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.
Xiao Y; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.
Zhang Q; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.
Rong R; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, China.; Pokaż więcej
Źródło:: Drug delivery [Drug Deliv] 2023 Dec; Vol. 30 (1), pp. 2171158.
Typ publikacji:: Journal Article
MeSH Terms:: Prodrugs*/pharmacokinetics
Antineoplastic Agents*/pharmacokinetics
Neoplasms*/drug therapy
Nanoparticles*
Humans ; Oxaliplatin ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Gasdermin D: A Potential New Auxiliary Pan-Biomarker for the Detection and Diagnosis of Diseases.
Autorzy:: Wan N; Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Shi J; Department of Clinical Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Xu J; Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Huang J; Department of Information Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Gan D; Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Tang M; Key Laboratory of Medical Diagnostics Designated by Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Li X; Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Huang Y; Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
Li P; Department of Clinical Laboratory, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2023 Nov 17; Vol. 13 (11). Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Intracellular Signaling Peptides and Proteins*
Neoplasms*/diagnosis
Humans ; Gasdermins ; Pyroptosis ; Apoptosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Circulating IL-17 reduces the risk of cisplatin-induced hearing loss in children: a bidirectional two-sample Mendelian randomization study.
Autorzy:: Xu Y; Department of Hematology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
Huang C; Department of Hematology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
Liu J; Department of Hematology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
Xu Y; Department of Endocrinology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
Yang H; Department of Hematology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 02; Vol. 13 (1), pp. 18957. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:: Meta-Analysis; Journal Article
MeSH Terms:: Antineoplastic Agents*/therapeutic use
Hearing Loss*/chemically induced
Hearing Loss*/genetics
Hearing Loss*/drug therapy
Neoplasms*/drug therapy
Deafness*
Humans ; Child ; Cisplatin/therapeutic use ; Macrophage Colony-Stimulating Factor ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Interleukin-17/genetics ; Cytokines/therapeutic use ; Multicenter Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Cohort profile: design and methods of the Chinese colorectal, breast, lung, liver, and stomach cancer screening trial (C-BLAST).
Autorzy:: Huang Y; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Lyu Z; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Zhang Y; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Liu X; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Zhang Y; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Liu Y; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Sheng C; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Duan H; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Fan Z; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Li C; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Lin X; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Feng Z; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Zheng L; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Ye Z; Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Lu H; Department of Breast Imaging Diagnosis, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Zhu Y; Department of Breast Imaging Diagnosis, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Zhou D; Department of Endoscopy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Wei X; Department of Ultrasound Imaging Diagnosis, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Ren L; Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Meng B; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Song F; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Song F; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Chen K; Department of Cancer Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology (Tianjin), Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.; Pokaż więcej
Corporate Authors:: C-BLAST Group
Źródło:: Cancer biology & medicine [Cancer Biol Med] 2023 Oct 27; Vol. 20 (10).
Typ publikacji:: Editorial; Research Support, Non-U.S. Gov't
MeSH Terms:: Early Detection of Cancer*/methods
East Asian People*
Neoplasms*/diagnosis
Neoplasms*/epidemiology
Neoplasms*/ethnology
Humans ; Colorectal Neoplasms/diagnosis ; Liver ; Lung ; Stomach Neoplasms/diagnosis

Raport

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: DNA damage induced by CDK4 and CDK6 blockade triggers anti-tumor immune responses through cGAS-STING pathway.
Autorzy:: Fan H; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.
Liu W; Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.
Zeng Y; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.
Zhou Y; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Gao M; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.
Yang L; Department of Gastroenterology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, No. 158 Shangtang Road, Hangzhou, Zhejiang, China.
Liu H; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.; Department of Pharmacy, China Pharmaceutical University, No. 24 Tongjiaxiang Road, Nanjing, 210009, China.
Shi Y; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.
Li L; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.
Ma J; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.
Ruan J; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.; Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.
Cao R; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.; Department of Pharmacy, China Pharmaceutical University, No. 24 Tongjiaxiang Road, Nanjing, 210009, China.
Jin X; The Affiliated Tumor Hospital of Nantong University, Nantong Tumor Hospital, Nantong, Jiangsu, China. .
Chen J; The Affiliated Tumor Hospital of Nantong University, Nantong Tumor Hospital, Nantong, Jiangsu, China. .
Cheng G; Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, CA, USA. .
Yang H; National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China. .; Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China. .; Pokaż więcej
Źródło:: Communications biology [Commun Biol] 2023 Oct 13; Vol. 6 (1), pp. 1041. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cyclin-Dependent Kinase 4*/genetics
Cyclin-Dependent Kinase 4*/metabolism
Cyclin-Dependent Kinase 6*/genetics
Cyclin-Dependent Kinase 6*/metabolism
Interferon Type I*/pharmacology
Neoplasms*/drug therapy
Neoplasms*/genetics
Humans ; Immunity ; Nucleotidyltransferases/genetics ; Nucleotidyltransferases/metabolism ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Autorzy:: Li YR; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, 90095, USA. .
Fang Y; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Lyu Z; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Zhu Y; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Yang L; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, 90095, USA. .; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA, 90095, USA. .; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA. .; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, 90095, USA. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Oct 02; Vol. 21 (1), pp. 686. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoplasms*/pathology
Humans ; Immunotherapy ; Cell Transformation, Neoplastic ; Neoplastic Stem Cells/pathology ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: A Versatile PDA(DOX) Nanoplatform for Chemo-Photothermal Synergistic Therapy against Breast Cancer and Attenuated Doxorubicin-Induced Cardiotoxicity.
Autorzy:: Geng S; School of Life and Environmental Sciences, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Feng Q; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Wang C; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Li Y; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Qin J; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Hou M; Department of Pathology, Shaoxing Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, 312000, People's Republic of China.
Zhou J; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Pan X; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Xu F; Department of Ultrasound, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Fang B; School of Life and Environmental Sciences, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Wang K; School of Life and Environmental Sciences, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China.
Yu Z; School of Life and Environmental Sciences, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China. .; Laboratory of Nanomedicine, Medical Science Research Center, School of Medicine, Shaoxing University, Shaoxing, Zhejiang, 312000, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2023 Sep 21; Vol. 21 (1), pp. 338. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:: Journal Article
MeSH Terms:: Hyperthermia, Induced*
Neoplasms*
Humans ; Photothermal Therapy ; Cardiotoxicity/etiology ; Cardiotoxicity/prevention & control ; Doxorubicin/pharmacology ; Anthracyclines ; Antioxidants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study.
Autorzy:: Noh S; Division of Critical Care, Pulmonary and Sleep Medicine, McGovern Medical School, Houston, Texas, USA.
Bertini C; Department of Internal Medicine, McGovern Medical School at UT Health, Houston, Texas, USA.
Mira-Avendano I; Division of Critical Care, Pulmonary and Sleep Medicine, McGovern Medical School, Houston, Texas, USA.
Kaous M; Division of Critical Care, Pulmonary and Sleep Medicine, McGovern Medical School, Houston, Texas, USA.
Patel B; Division of Critical Care, Pulmonary and Sleep Medicine, McGovern Medical School, Houston, Texas, USA.
Faiz SA; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Shannon VR; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Balachandran DD; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Bashoura L; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Adachi R; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Evans SE; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Dickey B; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wu C; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Shroff GS; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Manzano JG; Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Granwehr B; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Holloway S; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Dickson K; Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Mohammed A; Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Muthu M; Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Song H; Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Chung C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wu J; Department of Imaging Physics, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lee L; Department of Internal Medicine, McGovern Medical School at UT Health, Houston, Texas, USA.
Jiang Y; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Khawaja F; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sheshadri A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Pokaż więcej
Corporate Authors:: D3CODE Team; Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Źródło:: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 17753-17765. Date of Electronic Publication: 2023 Aug 18.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: COVID-19*/complications
Neoplasms*/complications
Neoplasms*/epidemiology
Humans ; Prospective Studies ; Aftercare ; SARS-CoV-2 ; Patient Discharge ; Lung/diagnostic imaging ; Hospitalization

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Involvement of lncRNAs in the tumor microenvironment: a new property of tumor immunity.
Autorzy:: Lin Q; School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China.; Zhengzhou Research Institute of Harbin Institute of Technology, Zhengzhou 450000, China.; Key Laboratory of Science and Engineering for the Multi-modal Prevention and Control of Major Chronic Diseases, Ministry of Industry and Information Technology, Zhengzhou 450000, China.
Zhu J; Zhengzhou Research Institute of Harbin Institute of Technology, Zhengzhou 450000, China.; School of Astronautics, Harbin Institute of Technology, Harbin 150001, China.
Hu Y; School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China.; Zhengzhou Research Institute of Harbin Institute of Technology, Zhengzhou 450000, China.; Key Laboratory of Science and Engineering for the Multi-modal Prevention and Control of Major Chronic Diseases, Ministry of Industry and Information Technology, Zhengzhou 450000, China.; Pokaż więcej
Źródło:: Cancer biology & medicine [Cancer Biol Med] 2023 Aug 26; Vol. 20 (8).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: RNA, Long Noncoding*/genetics
Neoplasms*/genetics
Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Ying Y"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język